Clinical problems in radiotherapy of carcinoma of the pancreas.
Since 1975, 94 patients with localized unresectable carcinoma of the pancreas have been irradiated using helium and heavier particles at the University of California Lawrence Berkeley Laboratory. Despite surgical exploration and an extensive diagnostic workup including radiological, nuclear medicine, and computer-assisted tomographic studies, many patients proved to have occult liver metastases manifested within 9 months post treatment. In addition, local and regional control of the primary neoplasm (approximately 20%) has been difficult to obtain even with doses of 6000 equivalent rad in 7 1/2 weeks. Gastric and biliary obstruction have required surgical bypass procedures since irradiation has not been successful in relieving obstructive symptoms. Evidence of gastrointestinal injury has been present in postradiation therapy in approximately 10% of patients, a figure which might be higher if more patients had a longer survival (average 10 months). Some patients require pancreatic enzyme supplementation because of pancreatic deficiency either secondary to tumor or treatment. Further improvement in local control and survival requires better diagnostic methods for evaluation of local and metastatic spread, improved therapy for local and regional disease, as well as therapy directed at occult liver metastases that are frequently present.
D000230:Adenocarcinoma / Q000175:diagnosis / Q000532:radiotherapy*; D000512:Alpha Particles; D002986:Clinical Trials as Topic; D005472:Fluorouracil / Q000627:therapeutic use; D006371:Helium / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000532:radiotherapy*; D011897:Random Allocation; D014057:Tomography, X-Ray Computed
D006371:Helium; D005472:Fluorouracil